Implications of the MSLT-1 for sentinel lymph node biopsy in cutaneous head and neck melanoma.
Melanoma and Sarcoma Unit, Department of Surgical Oncology, Medical School of Crete University Hospital, Heraklion, Greece.
E
E
de Bree
Department of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands(1); Department of Otolaryngology-Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: R.deBree@umcutrecht.nl.
R
R
de Bree
D006258:Head and Neck Neoplasms / Q000473:pathology*; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000175:diagnosis*; D008545:Melanoma / Q000473:pathology*; D015337:Multicenter Studies as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000473:pathology*